Literature DB >> 34808103

Dysglycemia and incident heart failure among blacks: The jackson heart study.

Justin B Echouffo-Tcheugui1, Stanford E Mwasongwe2, Solomon K Musani3, Michael E Hall3, Adolfo Correa3, Adrian F Hernandez4, Sherita H Golden5, Robert J Mentz4, Alain G Bertoni6.   

Abstract

BACKGROUND: We aimed to investigate the associations of glycemic markers (hemoglobin A1C [HbA1C], fasting plasma glucose [FPG] and glycemic status [normoglycemia, prediabetes and diabetes]) with incident heart failure (HF) and its subtypes, among Blacks.
METHODS: We included 2,290 community-dwelling Blacks (64% women, mean age 58 years) without prevalent HF from the Jackson Heart Study who attended the second exam (2005 - 2008). The associations between glycemic markers and incident HF (and subtypes including HF with preserved ejection fraction [HFpEF] and reduced ejection fraction [HFrEF]) were evaluated using Cox proportional hazards regression models, adjusting for risk factors and coronary heart disease.
RESULTS: There were 119 incident HF events (48 HFpEF, 58 HFrEF, and 13 unclassified HF events) over a median follow-up of 10.5 years. Higher levels of HbA1C (HR per SD increment, 1.30; 95% CI 1.12, 1.51) and FPG (HR per SD increment FPG: 1.32; 95% CI: 1.17, 1.48) were associated with a higher risk of incident HF. Compared to normal glycemia, diabetes status was associated with a higher risk of incident HF (HR: 1.24; 95%CI: 1.02, 2.05). HbA1C was significantly associated with higher risks of HFpEF (HR per SD increment: 1.41, 95% CI: 1.18, 1.69) and HFrEF (HR per SD increment: 1.32; 95% CI: 1.12, 1.56). FPG was significantly associated with higher risk of HFpEF (HR per SD increment: 1.35, 95% CI: 1.14, 1.62) but not HFrEF (HR per SD increment: 1.12; 95% CI: 0.53, 2.35).
CONCLUSIONS: Among community-dwelling Blacks, higher levels of glycemic markers were associated with higher risk of HF subtypes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34808103      PMCID: PMC8844096          DOI: 10.1016/j.ahj.2021.11.003

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  26 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 2.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Authors:  Francesco Cosentino; Peter J Grant; Victor Aboyans; Clifford J Bailey; Antonio Ceriello; Victoria Delgado; Massimo Federici; Gerasimos Filippatos; Diederick E Grobbee; Tina Birgitte Hansen; Heikki V Huikuri; Isabelle Johansson; Peter Jüni; Maddalena Lettino; Nikolaus Marx; Linda G Mellbin; Carl J Östgren; Bianca Rocca; Marco Roffi; Naveed Sattar; Petar M Seferović; Miguel Sousa-Uva; Paul Valensi; David C Wheeler
Journal:  Eur Heart J       Date:  2020-01-07       Impact factor: 29.983

Review 3.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

Review 4.  Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis.

Authors:  Sebhat Erqou; Chee-Tin Christine Lee; Matthew Suffoletto; Justin B Echouffo-Tcheugui; Rudolf A de Boer; Joost P van Melle; Amanda I Adler
Journal:  Eur J Heart Fail       Date:  2012-10-25       Impact factor: 15.534

5.  Glycemic status and incident heart failure in elderly without history of diabetes mellitus: the health, aging, and body composition study.

Authors:  Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Tamara B Harris; Stephen B Kritchevsky; Douglas C Bauer; Andrew L Smith; Elsa Strotmeyer; Anne B Newman; Peter W F Wilson; Bruce M Psaty; Javed Butler
Journal:  J Card Fail       Date:  2009-04-25       Impact factor: 5.712

6.  The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF.

Authors:  Nazir Savji; Wouter C Meijers; Traci M Bartz; Vijeta Bhambhani; Mary Cushman; Matthew Nayor; Jorge R Kizer; Amy Sarma; Michael J Blaha; Ron T Gansevoort; Julius M Gardin; Hans L Hillege; Fei Ji; Willem J Kop; Emily S Lau; Douglas S Lee; Ruslan Sadreyev; Wiek H van Gilst; Thomas J Wang; Markella V Zanni; Ramachandran S Vasan; Norrina B Allen; Bruce M Psaty; Pim van der Harst; Daniel Levy; Martin Larson; Sanjiv J Shah; Rudolf A de Boer; John S Gottdiener; Jennifer E Ho
Journal:  JACC Heart Fail       Date:  2018-07-11       Impact factor: 12.035

7.  The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study.

Authors:  Kunihiro Matsushita; Saul Blecker; Antonio Pazin-Filho; Alain Bertoni; Patricia P Chang; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

8.  Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people.

Authors:  Anoop Dinesh Shah; Claudia Langenberg; Eleni Rapsomaniki; Spiros Denaxas; Mar Pujades-Rodriguez; Chris P Gale; John Deanfield; Liam Smeeth; Adam Timmis; Harry Hemingway
Journal:  Lancet Diabetes Endocrinol       Date:  2014-11-11       Impact factor: 32.069

9.  Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.

Authors:  Darren K McGuire; Weichung J Shih; Francesco Cosentino; Bernard Charbonnel; David Z I Cherney; Samuel Dagogo-Jack; Richard Pratley; Michelle Greenberg; Shuai Wang; Susan Huyck; Ira Gantz; Steven G Terra; Urszula Masiukiewicz; Christopher P Cannon
Journal:  JAMA Cardiol       Date:  2021-02-01       Impact factor: 14.676

10.  Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.

Authors:  Milton Packer; Javed Butler; Faiez Zannad; Gerasimos Filippatos; Joao Pedro Ferreira; Stuart J Pocock; Peter Carson; Inder Anand; Wolfram Doehner; Markus Haass; Michel Komajda; Alan Miller; Steen Pehrson; John R Teerlink; Sven Schnaidt; Cordula Zeller; Janet M Schnee; Stefan D Anker
Journal:  Circulation       Date:  2021-08-29       Impact factor: 29.690

View more
  2 in total

1.  Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Justin B Echouffo-Tcheugui; Oluseye Ogunmoroti; Sherita H Golden; Alain G Bertoni; Morgana Mongraw-Chaffin; Ambarish Pandey; Chiadi E Ndumele; Erin D Michos
Journal:  J Card Fail       Date:  2022-01-31       Impact factor: 6.592

2.  Causal Association of Type 2 Diabetes Mellitus and Glycemic Traits With Cardiovascular Diseases and Lipid Traits: A Mendelian Randomization Study.

Authors:  Mingkai Huang; Loum-Davadi Laina-Nicaise; Lingfeng Zha; Tingting Tang; Xiang Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.